YDK-28543-94063

3 vaccinations 13 coded responses 32 check-ins 13 free-text entries 3 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 652 / MO
Registered: 2021-03-31

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-30
Dose 1 — Moderna
2021-03-31
Registered in v-safe
2021-03-31
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Vertigo — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Dizziness, vertigo (moderate to severe)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-01
Survey response — days 1–6 daily, dose 1
MedDRA: Vertigo — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Vertigo (moderate)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Survey response — days 1–6 daily, dose 1
MedDRA: Vertigo — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Vertigo (mild)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-27
Dose 2 — Moderna
2021-04-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-28
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Dizziness/lightheadedness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Lightheadedness - moderate/severe

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-05-04
Health check-in — day 7, dose 2
Feeling: Fair · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-05-11
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-05-18
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-25
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-06-01
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-06-08
Survey response — day 42, dose 2
MedDRA: Intermenstrual bleeding, Menstrual disorder — Feeling: Good

Free text: I menstrual cycle has been abnormal. Ive been spotting between periods, which never happens. No new medications or supplements, only change is vaccine. Seems to be frequent among women who have received the vaccine, yet not listed as side effect??

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-29
Survey response — 3 months, dose 2
MedDRA: Intermenstrual bleeding — Feeling: Good

Free text: Still spotting between periods, which has only been happening since my second dose.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-10-26
Survey response — 6 months, dose 2
MedDRA: Menstrual disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Still having issues related to menstrual cycle since receiving second dose.

MedDRA releases: 2024-11 · check-in free text available
2021-10-26
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-10-28
Call 1 — Left Voicemail
2021-10-28
Call successful
Participant prefers to complete VAERS report online
2021-11-19
Dose 3 — Moderna
Co-administered: Flu
2021-11-20
Survey response — days 1–6 daily, dose 3
MedDRA: Dizziness, Dysgeusia — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Lightheadedness, metallic taste in mouth

MedDRA releases: 2024-11 · check-in free text available
2021-11-21
Survey response — days 1–6 daily, dose 3
MedDRA: Dysgeusia — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Metallic taste in mouth

MedDRA releases: 2024-11 · check-in free text available
2021-11-22
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-24
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-25
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-11-28
Health check-in — day 7, dose 3
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-05
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-12-10
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-18
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-24
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2022-01-02
Survey response — day 42, dose 3
MedDRA: Exposure to SARS-CoV-2, Nasal congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Stuffy nose after exposure to Covid-positive person (spouse). Test scheduled for tomorrow.

MedDRA releases: 2024-11 · check-in free text available
2022-01-02
Report sent to call center — day 42, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-04
Call 1 — Left Voicemail
2022-02-18
Survey response — 3 months, dose 3
MedDRA: Bronchitis, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Contracted Covid and am now being treated for post-Covid bronchitis

MedDRA releases: 2024-11 · check-in free text available
2022-02-18
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-24
Call 1 — Left Voicemail
2022-02-24
Call successful
Participant prefers to complete VAERS report online
2022-05-20
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-21
Survey response — 12 months, dose 3
MedDRA: Respiratory tract congestion — Feeling: Good

Free text: Congestion

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-30	Moderna
2	2021-04-27	Moderna
3	2021-11-19	Moderna	Flu

Call center

Reported	Outcome	VAERS-related outcome
2021-10-26	Successful 2021-10-28	Participant prefers to complete VAERS report online
2022-01-02	Successful	Participant prefers to complete VAERS report online
2022-02-18	Successful 2022-02-24	Participant prefers to complete VAERS report online

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-31

Systemic reaction (other): Dizziness, vertigo (moderate to severe)

2021-04-01

Systemic reaction (other): Vertigo (moderate)

2021-04-02

Systemic reaction (other): Vertigo (mild)

Release 8 — days 1–6 daily, dose 2

2021-04-28

Systemic reaction (other): Dizziness/lightheadedness

2021-04-29

Systemic reaction (other): Lightheadedness - moderate/severe

Release 8 — day 42, dose 2

2021-06-08

Symptoms: I menstrual cycle has been abnormal. Ive been spotting between periods, which never happens. No new medications or supplements, only change is vaccine. Seems to be frequent among women who have received the vaccine, yet not listed as side effect??

Release 9 — 3 months, dose 2

2021-07-29

Symptoms: Still spotting between periods, which has only been happening since my second dose.

Release 10 — 6 months, dose 2

2021-10-26

Symptoms: Still having issues related to menstrual cycle since receiving second dose.

Release 10 — days 1–6 daily, dose 3

2021-11-20

Systemic reaction (other): Lightheadedness, metallic taste in mouth

2021-11-21

Systemic reaction (other): Metallic taste in mouth

Release 10 — day 42, dose 3

2022-01-02

Symptoms: Stuffy nose after exposure to Covid-positive person (spouse). Test scheduled for tomorrow.

Release 11 — 3 months, dose 3

2022-02-18

Symptoms: Contracted Covid and am now being treated for post-Covid bronchitis

Release 12 — 12 months, dose 3

2022-11-21

Symptoms: Congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bronchitis	·	·	✓
SD	Exposure to SARS-CoV-2	·	·	✓
SD	Intermenstrual bleeding	✓	✓	✓
SD	Menstrual disorder	✓	✓	✓
SD	Nasal congestion	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Dysgeusia	·	·	✓
SRO	Vertigo	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release